Decoy Therapeutics

Decoy Therapeutics is a biotechnology company dedicated to developing a new method for treating viral diseases. The company is pioneering the design of Designed Multivalent Antivirals (DMAVs), a novel class of antiviral drugs aimed at targeting shared mechanisms in viruses. By focusing on mechanisms conserved across various viruses, DMAVs are designed to enable a single multi-purpose drug to combat multiple viral threats, surpassing the traditional "one virus, one drug" model. Decoy’s lead programs are centered on respiratory viruses that continue to cause significant health and societal disruption globally. By designing antiviral drugs that reflect how viral threats manifest in the real world, the company aims to expand the possibilities for prevention and treatment.